Bionovo, Inc. (NASDAQ: BNVI)

Bionovo, Inc. (NASDAQ: BNVI), a drug discovery and development company, has their focus on developing safe and effective drugs to treat unmet medical needs in women’s health and cancer. Their aim is to improve the quality of women’s health and defeat life-threatening cancers. The company has a diverse pipeline of preclinical drug candidates to address both women’s health and cancer, and have identified or begun preclinical work on several multiple drug candidates for a variety of indications. For further information, visit the Company’s web site at www.bionovo.com.